Buforin II vs Tachyplesin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Buforin II is a 21-residue antimicrobial peptide derived from histone H2A in the stomach of the Asian toad Bufo gargarizans. Unlike most AMPs that kill bacteria by membrane disruption, Buforin II translocates across bacterial membranes without causing lysis and kills by binding n...
Calculate Buforin II dose →Tachyplesin I is an 18-residue disulfide-bridged beta-hairpin AMP from the hemocytes of the Japanese horseshoe crab (Tachypleus tridentatus). It exhibits potent antimicrobial, antiviral, and antitumor activity....
Calculate Tachyplesin dose →| Parameter | Buforin II | Tachyplesin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Preclinical |
| Half-Life | Minutes (proteolytic) | Hours (disulfide stabilized) |
| Typical Dose | N/A | N/A |
| Frequency | N/A | N/A |
| Route | Research only | Research only |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.